Connect the key reports
Organize biopsy and surgery reports, stage, scans, and ER, PR, and HER2 results. Keep treatment history and relevant genetic or genomic test reports alongside them.
Bring your mammograms, family history, and questions into one place. Understand screening guidance and stay informed through every stage of care.
Mammogram report
Keep the recommendation beside the result
When should my next mammogram be, given my history?
A QUESTION TO BRING TO YOUR CLINICIANYour age is one part of the picture. Previous imaging, family history, and known risk factors help shape the conversation.
The USPSTF recommends a mammogram every two years from ages 40–74 for women and other people assigned female at birth covered by its recommendation. Some higher-risk histories require a different pathway. Read the guidance.
Known high-risk genetic findings, prior chest radiation at a young age, or certain personal histories may change screening. ACS guidance includes MRI with mammography for some high-risk people. See high-risk guidance.
A new lump, nipple change, or other breast symptom needs clinical evaluation. Do not wait for a routine screening date. Dense breasts and prior findings are useful context, but they do not by themselves determine the next test.
Add previous tests, relevant history, and the changes you have noticed.
Explore guidance, see what is missing, and keep your questions visible.
Bring a useful history and focused questions to your care team.
Keep the original reports and the details behind a family history. They can make recommendations much easier to understand.
A guide to the information to collect. You do not need to enter any personal information on this page.
Your age, sex assigned at birth, relevant anatomy and surgeries, hormone use, and whether you currently have breast symptoms. These details help a clinician interpret which screening guidance applies.
Dates and results of previous mammograms, ultrasound, or MRI; breast density; BI-RADS category if available; biopsy findings; and any recommended follow-up. Include the reports, not just “normal” or “abnormal.”
Which relatives had breast, ovarian, pancreatic, or prostate cancer, and their ages at diagnosis. Include known inherited variants and any genetic counseling or testing reports.
Previous breast cancer, high-risk breast lesions, chest radiation, and relevant reproductive history. Record any new lump, skin or nipple change, discharge, or focal pain and when it began.
Recorded location and when it started
Added impact on daily activities
Saved a question about the imaging report
Keep track of what you notice, where it occurs, and how it changes. During treatment, add the symptoms and side effects your care team asks you to monitor.
A breast cancer diagnosis is not a single treatment story. Your pathology, stage, and preferences help frame the choices you discuss with your team.
Organize biopsy and surgery reports, stage, scans, and ER, PR, and HER2 results. Keep treatment history and relevant genetic or genomic test reports alongside them.
Explore surgery, radiation, chemotherapy, hormone therapy, targeted therapy, and immunotherapy where relevant. Learn why receptor status, stage, prior treatment, and your goals can change the conversation.
Review the purpose and demands of a study alongside subtype, stage, prior therapies, and other eligibility requirements. Availability and fit must be confirmed by the trial team.
Use what you learn to ask more focused questions and make decisions with your care team.
NCI: breast cancer treatmentSometimes. The number of relatives, their relationship to you, their ages at diagnosis, and the types of cancer all matter. A clinician may recommend a more detailed risk assessment or genetic counseling.
Density is an imaging description that can affect how mammograms are interpreted and is one part of risk assessment. Decisions about additional imaging depend on your full situation. The USPSTF finds insufficient evidence to recommend for or against supplemental ultrasound or MRI solely for dense breasts after a negative mammogram.
Contact a clinician for evaluation. Routine screening schedules are for people without symptoms; a new symptom may need a different kind of assessment.
No. It is designed to help you understand information and prepare questions. Treatment decisions belong with you and your clinical team, using your complete history and preferences.
U.S. guidance and patient education.
Reviewed for this draft: November 2026.
Recommendations can change. A clinician should confirm which guidance applies to your situation.
Bring your history, questions, and next steps together.
Start my health story